Figure 2
From: Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate
Behavioural effects of short-term agmatine treatment. Mean (±SEM) time spent in open (A) and enclosed (B) arms of the elevated plus maze, and path length (C) and % time spent in the outer zone (D) of the open field apparatus in wild-type mice received intraperitoneal (IP) injection of agmatine at 0 or 40 mg/kg or oral gavage of agmatine at 0, 300, 600 and 900 mg/kg (n = 4–5/group).
